CS Paper Radar

Label-Space Mismatch Distorts Cross-Cohort Evaluation in Breast Cancer Molecular Subtyping

Suxing Liu, Byungwon Min, Zhijian Zheng, Jiahao Wang

cs.LG cs.AIq-bio.QM ·submitted 2026-10-18 02:25 UTC · v1

Abstract

Cross-cohort evaluation of breast cancer subtype classifiers is unreliable when source and target cohorts use different annotation standards: METABRIC labels six classes, PAM50 defines five, and a claudin-low prediction cannot be correct under a five-class standard. A classifier transferred from 1,369 METABRIC patients (train n=958) to TCGA-BRCA (n=987) and GSE21653 (n=266) separates three evaluation operations routinely conflated in cross-site comparisons. (1) Label-space restriction - an evaluation-rule change, not a retraining gain - is the dominant correction (73.76%->79.74% on TCGA-BRCA; 63.16%->68.42% on GSE21653); (2) EM prior correction on the reconciled space is an optional calibration step (Brier fidelity up, macro F1 down; to 80.65% and 74.06%); and (3) the target label space is not recoverable from unlabelled predictions (EM retains prior 0.0751 on the absent class; calibrated detectors fail), so compliance must come from cohort documentation. The protocol exposes why internal validation overstates cross-cohort value: multimodal fusion gains do not transfer (no configuration beats mRNA alone, n=694; McNemar p=0.13-1.00), and the genomic panel adds nothing to pathological complete response prediction over clinical variables (DeltaAUC = +0.0045). Clinically, without label-space compliance, cross-site accuracy comparisons misattribute annotation-standard differences to model skill; Luminal A/B and claudin-low boundary errors map to distinct treatment decisions; and subtype accuracy is a weaker portable endpoint than survival discrimination (external C-index 0.577-0.584). Reporting the cohort's allowed label set and applying label-space compliance are therefore prerequisites before any cross-cohort performance claim.

Closest papers

Nearest neighbours by meaning across the whole index.

Ensemble Classification and Cancer-Specific Gene Signatures from Quality-Aware Hybrid Gene Selection in TCGA RNA-Seq data

cs.LG ·2026-10-31 ·Tareque Mohmud Chowdhury, Abu Raihan Mostofa Kamal
similarity 0.61
Abstract · 17 pages, 6 figures, 3 tables and 1 supplementary file

Gene-expression classifiers of cancer type are usually developed and validated within one cohort using random splits. Starting from a quality-aware hybrid Boruta selector from earlier work, we developed and evaluated ensemble classifiers and cancer-specific gene signatures. Using 10,469 TCGA tumours of 33 types, we compared five learners and three ensembles under decision rules fixed in advance, reran the selection in site-grouped cross-validation, transferred a breast-cancer subtype panel to 3273 tumours of the independent SCAN-B cohort, and built five-gene stage~I tumour versus adjacent-normal panels for nine cancer types. Logistic regression (LR) was the most accurate and best-calibrated single learner (balanced accuracy 0.943 on the locked test set). Stacking added at most 0.006 with 1000 genes but improved on LR in every fold with a minimal 100-gene panel; a hierarchical model did not reduce within-group confusion. Site-grouped validation lowered balanced accuracy by 0.027, almost entirely in colon and rectal cancer (0.008 without them and the untestable LAML). On SCAN-B, the subtype panel reached 0.855, close to the 50 PAM50 genes (0.876). Stage~I panels reached ROC AUC >= 0.99 in held-out patients and detected most later-stage tumours. Ensembles help most with a minimal panel; with 1000 genes, a calibrated linear model suffices.

0.26

Tree Depth and Sample-Quality-Associated Features: Two Hidden Factors in Boruta Selection for RNA-Seq Data Classification

cs.LG ·2026-10-23 ·Tareque Mohmud Chowdhury, Abu Raihan Mostofa Kamal
similarity 0.59
Abstract · 19 Pages, 6 Figures, 4 Tables

Random Forest--based selectors such as Boruta depend on tree depth, yet Boruta's most used implementation, BorutaPy, recommends depths of 3 to 7 without published evidence. We tested the effect of depth using pan-cancer data from The Cancer Genome Atlas (10,469 tumors, 33 cancer types) and breast cancer PAM50 subtyping (981 tumors, 5 subtypes). Label-dependent steps were fitted inside training folds, effects were measured against seed-to-seed variation, and each task kept a locked test set. In pan-cancer data, depth 5 changed the selection far more than a new seed did: the top-500 Jaccard overlap with unlimited depth was 0.37, against 0.84 (depth 5) and 0.93 (unlimited) between seeds. Depth-5 trees confirmed 472 instead of 1,659 genes, covered fewer large-class markers (16% vs 62%) and gave less accurate 50-gene panels (balanced accuracy 0.809 vs 0.889). The effect vanished once the cap reached 61 to 76% of the median depth of unrestricted trees, a depth that depends mainly on the number of classes, not sample size. In PAM50 subtyping (median depth 12) the effect was small, and leaving depth uncapped cost no accuracy in either task. It replicated in a second cross-validation repeat and under permutation importance. About a third of pre-filtered candidates correlated within class with the number of detected genes, a sample-quality measure; a within-class filter removed them without loss of test accuracy (0.943 vs 0.942 balanced accuracy, 1,000 genes). We recommend uncapped trees, or a cap above 75% of the realized median depth, and a within-class quality filter before Boruta.

0.49

Detecting Unreliable Classifications from Quantized Models

cs.CV ·2026-10-13 ·Ananya Kotla, Jorge T. Gomez
hot direction similarity 0.59
Abstract · 1 figure, 5 tables

Post-training INT8 quantization is typically validated by checking accuracy retention, which requires ground-truth labels often unavailable in low-resource clinical settings. We show a label-free alternative: comparing a model's own output before and after quantization. We compute cosine similarity between the FP32 and INT8 models' output probability vectors for each prediction, which requires only a single forward pass. This output-agreement similarity separates lower-accuracy predictions across four evaluated architectures (ResNet-50, VGG-16-BN, Wide ResNet-50, and ViT-B/16) under fixed-percentile splits, outperforming a confidence-only baseline for all four. These results show that quantized models can be compared to their baselines to assess their drift and determine whether they are well suited for clinical deployment.

0.31

PRISM: Pathology Reliability In Scarce-label Medicine. A Tile-level Benchmark of Pathology Foundation Models

cs.LG cs.CV ·2026-10-27 ·Alicem Koyun
publishedbenchmarkcode/data similarity 0.57
Abstract · 30 pages (9 main), 21 figures. Accepted at the Third Workshop on GenAI for Health (GenAI4Health) at NeurIPS 2026

Pathology foundation models are typically benchmarked on classification performance at full label availability and on in-distribution test sets, while calibration, behavior at low label budgets, and robustness under cross-institutional shift are seldom evaluated jointly. We introduce PRISM, a tile-level benchmark that measures the reliability of pathology foundation models along four axes: model choice, label fraction, calibration, and out-of-distribution transfer. PRISM evaluates eight foundation models (CLIP, PLIP, CONCH, UNI, Virchow2, GigaPath, H-Optimus-0, Midnight) on six tile-level datasets at six label fractions (1% to 100%) with three seeds (864 linear probe runs), extended with a five-hospital Camelyon17 study of 20 directed transfer pairs. Four phenomena emerge. (i) Under full supervision, AUROC rank predicts post-temperature calibration rank consistently across datasets (Spearman rho = 0.52, I^2 = 0%), whereas at 1% labels the relationship becomes dataset-specific (rho = -0.24, I^2 = 67%). (ii) On harder datasets the linear probe collapses to a single predicted class below a dataset-specific label fraction. (iii) Whether additional source-domain labels help or harm target calibration tracks how well the probe transfers: below a transfer AUROC of roughly 0.85, more labels worsen target ECE in 86-88% of combinations. (iv) Temperature scaling fails to reduce ECE in 49 of 288 cells, miscalibration is predominantly under-confidence, and a source-fitted temperature is harmful under failing transfer. PRISM is released as a pip-installable package with reference results for all 288 cells. Code and data: https://github.com/alicemkyn/prism-benchmark

0.46

Align Before You Combine: Reference Space Calibration for Supervision Without Ground Truth

cs.LG cs.AI ·2026-10-07 ·Jackson Eshbaugh, Jorge Silveyra
benchmarkcode/data similarity 0.57
Abstract · 25 pages; 14 tables; 4 figures; 5 appendices; code available at https://github.com/Lafayette-EshbaughSilveyra-Group/calibration-first

We introduce a calibration-first framework that produces supervision scores without access to ground-truth labels or a shared annotation space. Our framework aligns subset-specific scorers using a synthetic ordinal reference space before fusion. This reference space is constructed from ordered calibration features that represent the latent concept, providing a common scale on which otherwise incomparable scorer outputs can be aligned. Because our calibration procedure uses the reference space rather than training samples, it is independent of the training set's empirical distribution. Across three benchmark datasets, our framework consistently outperforms uncalibrated averaging and achieves higher primary-metric point estimates on the evaluation metrics than the best individual scorer. Performance relative to sample-dependent baselines varies by domain, with absolute differences below 0.02 on Ames Housing and below 0.01 on Breast Cancer Wisconsin and Wine Quality. After Bonferroni correction, differences remain significant for all three comparisons on Ames Housing and one on Breast Cancer Wisconsin. Additionally, we show that using fewer calibration levels per feature can closely approximate higher-resolution results at substantially lower computational cost. Together, these results support our framework as a viable approach to construct supervision scores when neither ground-truth labels nor a shared annotation space is available.

0.34

The Accuracy Paradox: Empirical Diagnostic of Default Decision Thresholds in Multi-Label Enzyme Commission Prediction [With Code]

cs.LG cs.AIq-bio.QM ·2026-09-07 ·Bilal Ahmad, Rajed Mehmood
code/data similarity 0.56
Abstract · 11 pages, 4 figures,Enzyme Commission prediction, multi-label classification, class imbalance, threshold optimization, conformal calibration…

Automated prediction of Enzyme Commission (EC) numbers plays a central role in functional annotation and computational drug discovery. However, standard multi-label machine learning pipelines frequently rely on default decision thresholds (t=0.50), assuming balanced prior distributions across target heads. In this study, we present a systematic empirical diagnostic of uncalibrated fixed decision boundaries operating under severe class imbalance across N = 14,096 annotated compounds categorized into six primary EC classes (EC1-EC6). Our results highlight a pronounced Accuracy Paradox: while the multi-label system achieves a deceivingly high mean accuracy of 77.16%, the macro F1-score (0.3976) and macro recall (0.3872) reveal severe predictive breakdown. Majority target classes suffer from hyper-sensitivity and over-prediction, whereas minority classes exhibit sharp recall decay, culminating in a total decision boundary collapse for EC6 (Recall = 0.00%) despite underlying discriminative power (ROC-AUC = 0.5857). Feature correlation analysis further reveals high linear redundancy among topological indices relative to fingerprint density metrics. Ultimately, this diagnostic study demonstrates that standard point predictions mask critical errors in bioinformatics workflows. We establish target-specific threshold optimization and post-hoc conformal calibration as essential, open-source post-processing safeguards for reliable applied machine learning and deep learning architectures.

0.37

The Ceiling Is in the Channel: Auditing Learner Gaps and Measurement Frontiers in Clinical Prediction

cs.AI ·2026-09-01 ·Sayeed Shafayet Chowdhury, Nusrat Jahan, Snehasis Mukhopadhyay, Shiaofen Fang, Vijay R. Ramakrishnan
similarity 0.56
Abstract

Clinical prediction can saturate for two different reasons: a fitted learner may fail to extract available information, or the recorded variables may impose a population frontier. We separate these quantities through the \emph{learner gap} and the \emph{measurement-channel ceiling}. Optimal balanced accuracy is characterized by total-variation separation, yielding architecture invariance, a sharp partial-identification result under replacement contamination, a cross-fitted ceiling estimator, and exact conditions for multimodal decision improvement. We add two finite-sample diagnostics, namely a label-permutation optimism floor and an underfit curve, and validate the audit on three real cohorts: UCI readmission ($n=99{,}343$), BRFSS diabetes ($n=253{,}680$), and NHANES HbA1c ($n=10{,}219$). Well-tuned gradient boosting nearly reaches the estimated frontier in UCI and BRFSS, whereas deliberately or practically deficient learners retain large gaps. NHANES yields a null difference between questionnaire and measured marginal frontiers but a significant joint complementarity gain, refining the simplistic claim that an objective modality must dominate. Across all cohorts, modest AUROC gains coexist with substantially larger Bayes decision-flip rates, and several architectures estimate similar frontiers while their achieved balanced accuracy differs sharply. A PRISMA-guided synthesis of 104 clinical tasks then shows that the same channel-level regularities recur across more than 18 disease categories: a broad but non-universal structured-clinical region, diminishing same-channel gains across model families, and higher performance when measurement channels change. The framework converts saturation from an empirical observation into an auditable decision: improve the learner when headroom remains; improve measurement when it does not.

0.18

TRUST: Threshold-Recalibrated Uncertainty-Safe Training for Certified Dismissal in Breast Cancer Screening

cs.CV cs.LG ·2026-08-31 ·Parham Hajishafiezahramini, Matthew Hamilton, Edward Kendall, Gregory Doyle, Oscar Meruvia Pastor
theory similarity 0.55
Abstract

Reducing the review of clearly cancer-negative screening mammograms could lower radiologist workload without compromising cancer detection. We propose a closed-loop threshold-aware training strategy in which the dismissal threshold is recalculated during training and used to penalize cancer-positive images that approach the dismissal region. We evaluated the method on NLBS and RSNA using five controlled training configurations, with case-level assessment based on a one-sided 99\% Clopper--Pearson upper bound for cancer prevalence among dismissed cases. The proposed model achieved the highest case-level dismissal rates at both 98\% and 95\% recall targets. On NLBS, dismissal reached 19.74\% and 21.70\%, while the cross-entropy baseline did not meet either recall target. On RSNA, dismissal improved from 7.04\% to 14.31\% and from 13.49\% to 19.69\%. In external RSNA$\to$NLBS evaluation, the proposed model achieved dismissal rates of 12.95\% and 19.87\% at the 98\% and 95\% recall targets, respectively. These results support closed-loop threshold-aware training for high-recall selective dismissal.

0.26